openPR Logo
Press release

Axillary Hyperhidrosis Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies-SweatBlock, Certain Dri, Duradry, Zerosweat. Allergan plc., Dermavant Sciences Inc.

08-28-2023 05:36 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

DelveInsight's "Axillary Hyperhidrosis Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the Axillary Hyperhidrosis market trends in the United States, EU4 (Germany, Spain, Italy, France), and the United Kingdom, and Japan.

Download Sample Report to know more @https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Axillary Hyperhidrosis Overview
Excessive underarm sweating is a symptom of the uncontrollable, uncomfortable, embarrassing, and socially isolating condition known as axillary hyperhidrosis (AHH). It has a tremendous impact on one's mental, bodily, and occupational health. Uncontrollable underarm sweating can frequently feel like wrecking one's life due to the agony of sweat trickling down one's sides, the shame of visible sweat stains, and the fear of being "discovered."

Axillary Hyperhidrosis Diagnosis
Two types of tests, quantitative tests and qualitative tests confirm the diagnosis of hyperhidrosis.

Axillary Hyperhidrosis Treatment
The choice of treatment depends on how severe the sweating is, the affordability of treatment, and whether a permanent solution is desired. The International Hyperhidrosis Society (IHHS) recommends a step-therapy approach in which patients would use conservative therapies first and step up to more invasive treatments depending on their responses.

First-line treatment: Topical antiperspirants and Qbrexza are considered as first-line treatment of primary axillary hyperhidrosis. Patients with primary axillary hyperhidrosis often use nonprescription products such as zirconium salts. Patients with severe disease may opt for botulin toxin injections

Second-line treatment: Botox treatment is considered a second-line treatment in patients who do not respond to topical medications. Further, oral pharmacological agents such as anticholinergics, beta-blockers, and benzodiazepines are also considered. Anticholinergics work quickly, with most individuals seeing some improvement within a week of starting. Limitations of their use include large dose adjustments and subsequent adverse effects (AEs), such as xerostomia, blurred vision, sedation, and urinary retention.

Click here to learn more about the Axillary Hyperhidrosis Market Landscape @https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Key Highlights from Axillary Hyperhidrosis Market Report
Key Pharmaceutical companies working in the Axillary Hyperhidrosis market include SweatBlock, Allergan plc., Dermavant Sciences Inc. and many others
Key Therapies involved in the Axillary Hyperhidrosis market include APX001, CD101, SCY078, and many others.
Learn more about the treatment market for Axillary Hyperhidrosis @https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

The Report Covers the Axillary Hyperhidrosis Epidemiology Segmented by:
Axillary Hyperhidrosis Incident Cases
Axillary Hyperhidrosis Prevelant Cases
Axillary Hyperhidrosis Treatment Cases
Axillary Hyperhidrosis Diagnosed Cases

Axillary Hyperhidrosis Drug Profile and Companies Covered
SweatBlock: APX001
Allergan plc: CD101
Dermavant Sciences Inc : SCY078
And many others

Learn more about the Key Companies and Emerging Therapies in the Axillary Hyperhidrosis Market @https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Table of Contents
Key Insights
Axillary Hyperhidrosis Introduction
Executive Summary of Leber Hereditary Axillary Hyperhidrosis
Disease Background and Overview
Axillary Hyperhidrosis Epidemiology and patient population
Axillary Hyperhidrosis Emerging Therapies
Axillary Hyperhidrosis Market Outlook
Axillary Hyperhidrosis Market Access and Reimbursement of Therapies
Axillary Hyperhidrosis Market Drivers
Axillary Hyperhidrosis Market Barriers
Appendix
Axillary Hyperhidrosis Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Axillary Hyperhidrosis Market Outlook report @ https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Related Reports
Axillary Hyperhidrosis Epidemiology Forecast
https://www.delveinsight.com/report-store/Axillary Hyperhidrosis -epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Axillary Hyperhidrosis Pipeline Forecast
https://www.delveinsight.com/report-store/Axillary Hyperhidrosis -pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Axillary Hyperhidrosis Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies-SweatBlock, Certain Dri, Duradry, Zerosweat. Allergan plc., Dermavant Sciences Inc. here

News-ID: 3184990 • Views:

More Releases from DelveInsight Business Research LLP

Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical Stage Assets, Pharma Collaborations, Regulatory Developments, and the Global Market Growth Prospects
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Current Drug Trials, Potential Breakthrough Therapies, Pharma R&D Initiatives, and Future Market Transformations
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinical Advances, Pharma Strategies, and Market Evolution
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action, Ongoing Clinical Trials, Pharma Collaborations, and the Future Outlook of the Therapeutics Landscape
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Stay ahead with the latest insights!

All 5 Releases


More Releases for Hyperhidrosis

Hyperhidrosis Market Massive Growth opportunity Ahead
Introduction Hyperhidrosis, a condition characterized by excessive sweating beyond physiological needs, affects millions of people worldwide. It often impacts quality of life, causing emotional distress, social withdrawal, and occupational challenges. Primary hyperhidrosis typically involves localized sweating in areas like the palms, soles, and underarms, while secondary hyperhidrosis is linked to systemic conditions or medications. The global hyperhidrosis market has been gaining traction due to rising awareness, increasing diagnosis rates, and advancements in
Major Growth Driver Identified in 2025 Hyperhidrosis Treatment Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts Hyperhidrosis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for hyperhidrosis treatment has significantly expanded in the latter years. It's projected to rise from $1.58 billion in 2024 to $1.67 billion in 2025, showcasing a compound annual growth rate (CAGR) of
Rising Prevalence Of Diabetes Mellitus Boosts The Hyperhidrosis Treatment Market …
The Hyperhidrosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Hyperhidrosis Treatment Market Size During the Forecast Period? The market size for hyperhidrosis treatment has seen significant growth in recent years. The market value is predicted to increase from $1.58 billion
Leading Element Driving Change in the Hyperhidrosis Treatment Market in 2025: Ri …
What combination of drivers is leading to accelerated growth in the hyperhidrosis treatment market? The hyperhidrosis treatment market is likely to be driven by the growing incidence of diabetes mellitus, a health condition that arises when the body fails to produce sufficient insulin or fails to respond to insulin appropriately, leading to abnormally high blood sugar levels. Diabetes tends to damage the nerves that control sweat glands, resulting in excessive sweating
Major Market Shift in Hyperhidrosis Treatment Industry: Introduction Of Wipe For …
What Is the Forecasted Market Size and Growth Rate for the Hyperhidrosis Treatment Market? The hyperhidrosis treatment market is projected to grow from $1.58 billion in 2024 to $1.67 billion in 2025, at a CAGR of 5.9%. The growth is driven by increasing awareness of the psychosocial impact of hyperhidrosis, cosmetic concerns, and regulatory support. The Hyperhidrosis Treatment market is projected to grow to $2.13 billion by 2029 at a CAGR of
Hyperhidrosis Treatment Market Segmentation and Analysis Report, 2027
Transparency Market Research (TMR) has published a new report on the global hyperhidrosis treatment market for the forecast period of 2019-2027. According to the report, the global hyperhidrosis treatment market was valued at ~US$ 1.2 Bn in 2018, and is projected to expand at a CAGR of ~4% from 2019 to 2027. The global market is driven by increase in awareness and acceptance of hyperhidrosis treatment due to the launch of